
Ca72-4 Tumor Marker
Price:
Get Latest Price
In Stock
Product Overview
Key Features
We are reputed enterprises for manufacturing, exporting and supplying a wide gamut of CA72-4 Tumor Marker to our customers at the cost effective rates.
CA72-4 (Carbohydrate Antigen72-4)
Compitable instrument: Luminex 200,TESMI F4000 .
Reference Value: 6.9U/ml
Tellgen also provide following Tumor markers and Tumor Marker control :
CA125
CA153
CA24-2
CYFRA21-1
AFP
CEA
CEA
total PSA
free PSA
free-I -hCG
CA19-9
NSE
SCCA
CA72-4
CA50
HE4
ProGRP
PGI/PGII
Control 1
Control 2
Control 3
Elevated CA 72-4 levels in serum and plasma have been reported in various malignant diseases including carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium. The highest diagnostic sensitivities, according to current studies, are found for carcinomas of the gastrointestinal tract and ovaries.
Although some benign diseases such as rheumatic diseases or ovary cysts may also result in elevated levels of CA 72-4, clinical studies demonstrated diagnostic specificity of more than 95% for gastrointestinal and ovarian malignancies. There is a good correlation between CA 72-4 levels and tumor stage and size.
CA 72-4 is the marker of choice for the therapeutic monitoring and follow-up care of gastrointestinal cancer patients. Suitable second markers are CA 19-9 or CEA. It has been used as an independent marker for the therapeutic monitoring and follow-up care of ovarian cancer patients, in particular in CA 125 negative patients.
CA72-4 (Carbohydrate Antigen72-4)
Compitable instrument: Luminex 200,TESMI F4000 .
Reference Value: 6.9U/ml
Tellgen also provide following Tumor markers and Tumor Marker control :
CA125
CA153
CA24-2
CYFRA21-1
AFP
CEA
CEA
total PSA
free PSA
free-I -hCG
CA19-9
NSE
SCCA
CA72-4
CA50
HE4
ProGRP
PGI/PGII
Control 1
Control 2
Control 3
Elevated CA 72-4 levels in serum and plasma have been reported in various malignant diseases including carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium. The highest diagnostic sensitivities, according to current studies, are found for carcinomas of the gastrointestinal tract and ovaries.
Although some benign diseases such as rheumatic diseases or ovary cysts may also result in elevated levels of CA 72-4, clinical studies demonstrated diagnostic specificity of more than 95% for gastrointestinal and ovarian malignancies. There is a good correlation between CA 72-4 levels and tumor stage and size.
CA 72-4 is the marker of choice for the therapeutic monitoring and follow-up care of gastrointestinal cancer patients. Suitable second markers are CA 19-9 or CEA. It has been used as an independent marker for the therapeutic monitoring and follow-up care of ovarian cancer patients, in particular in CA 125 negative patients.
Related Products
More Product From This seller
Company Details
Tellgen Corporation, Established in 2003 at Shanghai in Shanghai, is a leading Exporter of Diagnostic Equipment in China. Tellgen Corporation is one of Trade India's verified and trusted sellers of listed products. With extensive experience in supplying and trading CA72-4 Tumor Marker, Tellgen Corporation has made a reputed name for itself in the market with high-quality Tellgen Real Time PCR Machine , AFP (Alpha Fetoprotein), CA 50 Tumor Marker, etc.
Focusing on a customer-centric approach, Tellgen Corporation has a pan-India presence and caters to a huge consumer base throughout the country. Buy Diagnostic Equipment in bulk from Tellgen Corporation at Trade India quality-assured products.
Focusing on a customer-centric approach, Tellgen Corporation has a pan-India presence and caters to a huge consumer base throughout the country. Buy Diagnostic Equipment in bulk from Tellgen Corporation at Trade India quality-assured products.
Business Type
Exporter
Establishment
2003
Explore Related Categories
Seller Details
Shanghai, Shanghai
Ms. Emma Ma
Address
Building 1,No.115.Lane 572, Bibo roadi Free trade Areai Shanghaii China Shanghai, Shanghai, 201203, China
tumor markers in Shanghai
Report incorrect details